BOYER-CHAMMARD, Agnès,DODION, Pierre,COHEN, Roger B.
申请号：
AU2019233507
公开号：
AU2019233507A1
申请日:
2019.03.12
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
This invention relates to the use of NKG2A-targeting agents for the treatment of cancers, notably head and neck cancers, in a patient having received prior treatment with cetuximab. This invention also provides advantageous combination regimens for use with NKG2A-targeting agents for the treatment of cancers.
